Clinically Isolated Syndrome

Clinically isolated syndrome is a first episode of neurological symptoms that may or may not lead to multiple sclerosis. Understanding this condition and the risk factors that predict future disease development is crucial for making informed decisions about early treatment and monitoring.

Table of contents

• What is Clinically Isolated Syndrome?
• The Relationship Between CIS and Multiple Sclerosis
• Symptoms of Clinically Isolated Syndrome
• Areas of the Body Affected by CIS
• Causes and Risk Factors
• How is CIS Diagnosed?
• Predicting the Risk of Developing Multiple Sclerosis
• Treatment Approaches

What is Clinically Isolated Syndrome?

Clinically isolated syndrome is a term used to describe the first episode of neurological symptoms that lasts for at least 24 hours^[2][3]. This episode must occur in the absence of fever or infection and should not include features of brain disease called encephalopathy, which refers to widespread brain dysfunction^[2].

The condition can present in two different patterns. A monofocal episode occurs when damage affects just one area of the brain or spinal cord, resulting in a single symptom. In contrast, a multifocal episode involves damage in several places, which can lead to multiple symptoms occurring at the same time^[1][3].

The episode typically reaches its peak quite rapidly within two to three weeks^[2]. Most people experience a full or partial recovery after their first episode^[2].

The Relationship Between CIS and Multiple Sclerosis

Clinically isolated syndrome is often considered a possible first sign of multiple sclerosis, which is a chronic disease of the central nervous system involving inflammation and damage to the protective covering of nerves^[2][5]. However, not everyone who experiences CIS will go on to develop multiple sclerosis. Some people may have only this single episode and never experience further neurological symptoms^[3].

In 85% of young adults who develop multiple sclerosis, the disease begins with an acute episode of clinically isolated syndrome affecting the optic nerves, brainstem, or spinal cord^[2][7]. The course following CIS is highly variable. After 15 to 20 years, about one third of patients have a mild course with minimal or no disability, while half will develop a progressive form of multiple sclerosis with increasing disability^[2].

Symptoms of Clinically Isolated Syndrome

The symptoms of clinically isolated syndrome are similar to those experienced during a multiple sclerosis relapse. The main difference is that people with CIS experience only one episode, while MS patients experience multiple episodes over time^[1].

Common symptoms include^[1]:

• Numbness or tingling sensations
• Vision problems, such as double vision
• Spasticity or stiffness of the muscles
• Difficulty controlling the bladder or bowels
• Difficulty with walking and coordination
• Muscle weakness
• Paralysis
• Dizziness
• Shakiness
• Sexual dysfunction

Areas of the Body Affected by CIS

Clinically isolated syndrome is caused by inflammation and damage to myelin, the protective fatty substance that surrounds nerve cells in the brain and spinal cord, which together make up the central nervous system^[3]. This damage, called demyelination, disrupts the way nerve messages are carried to and from the brain, resulting in the symptoms people experience^[3].

• Optic nerve
• Brainstem
• Cerebellum
• Spinal cord
• Cerebral hemispheres

These are the typical locations where CIS presentations occur^[2][7].

Causes and Risk Factors

The exact reasons why inflammation and myelin damage occur in clinically isolated syndrome are not yet fully understood^[3]. However, several factors have been identified that may play a role.

People with CIS tend to be diagnosed between the ages of 20 and 40, though the condition can occur at any age^[1][2]. The condition is twice to three times more likely to occur in women than in men^[2].

Since the risk of multiple sclerosis is significantly higher when a parent has been diagnosed with the disease, genetic factors may play a role^[1]. The unusual relationship between a person’s geographic location during childhood and the risk of MS later in life suggests there may be environmental factors at work as well^[1].

Other possible risk factors include vitamin D deficiency, Epstein-Barr virus infection, smoking, certain genes related to the immune system, and various immunological abnormalities, though these are considered weak or uncertain risk factors^[5].

How is CIS Diagnosed?

A neurologist makes the diagnosis of clinically isolated syndrome^[3]. There is no single examination or test that can be used to diagnose CIS. The diagnostic process involves ruling out other possible causes for the symptoms^[3].

Diagnosis begins with the physician taking a detailed medical history and performing a neurological examination^[1]. Because no single clinical feature or diagnostic test is sufficient for diagnosis, the evaluation includes a combination of both clinical and additional studies^[2].

Diagnostic tests may include^[1]:

• A magnetic resonance imaging (MRI) scan of the brain and spinal cord
• A lumbar puncture, also known as a spinal tap, along with cerebrospinal fluid analysis
• Nerve function tests
• Blood tests to rule out other conditions that have similar symptoms

These investigations aim to exclude alternative causes and to define the risk for developing multiple sclerosis^[5]. Patients diagnosed with CIS will have routine checkups to determine if their condition is progressing toward MS^[1].

Predicting the Risk of Developing Multiple Sclerosis

Not everyone who experiences clinically isolated syndrome goes on to develop multiple sclerosis. Estimates vary widely, with figures ranging from 1 in 5 people up to 4 in 5, so it is possible that someone may never have any further symptoms^[3].

The most notable predictors for developing multiple sclerosis are clinically silent MRI lesions and the presence of oligoclonal bands in the cerebrospinal fluid^[2][5]. MRI scans can give a good idea of the risk of going on to develop MS^[3].

When an MRI scan shows several areas of damage, called lesions, to the brain or spinal cord that are similar to those seen in multiple sclerosis, the likelihood of developing MS is high^[2]. Studies have shown that if clinically silent brain lesions are seen on MRI, there is a 60 to 80 percent risk of developing multiple sclerosis within several years. If there are no lesions visible on the MRI, the chance of being diagnosed with MS in the same time period drops to 20 percent^[3].

The number of lesions present, as well as their size and location, can help predict the risk of a future multiple sclerosis diagnosis. The more areas of damage seen on an MRI scan at the time of the CIS, the higher the risk of developing MS in the future^[3].

Treatment Approaches

There is no cure for clinically isolated syndrome^[1]. However, treatment options are available, particularly for people at high risk of developing multiple sclerosis.

The data clearly shows that early treatment of CIS, especially in those who have MRI results showing brain lesions consistent with multiple sclerosis, can reduce the disease activity that may lead to long-term disability^[11]. Studies have demonstrated that early treatment with disease-modifying drugs can delay a second episode if someone is at high risk of developing MS^[3].

The FDA has approved medications to manage the symptoms of certain types of multiple sclerosis, and patients diagnosed with high-risk CIS may be prescribed one or more of these to delay the onset of MS and manage symptoms^[1]. These medications may be used to reduce the frequency and severity of episodes a patient experiences^[1].

Some medications can help reduce the inflammation that is closely linked to demyelination, which refers to the damage caused to the nerve cells’ protective layer^[11]. Other benefits of early treatment include prolonging the period between the CIS and MS diagnoses and combating the effects of cognitive impairment and depression^[11].

Choosing the right medication requires careful consideration of the risks and benefits, along with close collaboration with an experienced medical team^[1].